Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Daniel N CohenJeffrey A Sosman

Abstract

BRAF-inhibition (BRAFi) therapy for advanced melanoma carries a high rate of secondary cutaneous squamous cell carcinoma (cSCC) and risk of other cancers. UV radiation and α-genus human papillomavirus (HPV) are highly associated with SCC, but a novel role for β-genus HPV is suspected in BRAFi-cSCC. Cutaneous β-HPV may act in concert with host and environmental factors in BRAFi-cSCC. Primary BRAFi-cSCC tissue DNA isolated from patients receiving vemurafenib or dabrafenib from two cancer centers was analyzed for the presence of cutaneous oncogenic viruses and host genetic mutations. Diagnostic specimens underwent consensus dermatopathology review. Clinical parameters for UV exposure and disease course were statistically analyzed in conjunction with histopathology. Twenty-nine patients contributed 69 BRAFi-cSCC lesions. BRAFi-cSCC had wart-like features (BRAFi-cSCC-WF) in 22% of specimens. During vemurafenib therapy, BRAFi-cSCC-WF arose 11.6 weeks more rapidly than conventional cSCC when controlled for gender and UV exposure (P value = 0.03). Among all BRAFi-cSCC, β-genus HPV-17, HPV-38, HPV-111 were most frequently isolated, and novel β-HPV genotypes were discovered (CTR, CRT-11, CRT-22). Sequencing revealed 63% of evaluated BRAF...Continue Reading

References

Apr 1, 1996·Photochemistry and Photobiology·A ZieglerD E Brash
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Susanne PoppPetra Boukamp
Jan 15, 2003·Journal of Virology·Sandra CaldeiraMassimo Tommasino
Jun 9, 2004·Virology·Ethel-Michele de VilliersHarald zur Hausen
Oct 19, 2004·Journal of Virological Methods·Andrea L Fuessel HawsStephen K Tyring
Aug 19, 2007·The Journal of Infectious Diseases·Ola ForslundUNKNOWN Viraskin Study Group
Jan 11, 2008·The Journal of Investigative Dermatology·Maryam M AsgariEthel-Michele de Villiers
Jan 19, 2008·Science·Huichen FengPatrick S Moore
Sep 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Masahiro ShudaYuan Chang
Jun 26, 2009·The Journal of Investigative Dermatology·Amy M DworkinAmanda E Toland
Oct 24, 2009·The British Journal of Dermatology·A ZaravinosD A Spandidos
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
May 17, 2011·Journal of the American Academy of Dermatology·Jennifer C SriAnthony A Gaspari
Jun 2, 2011·International Journal of Cancer. Journal International Du Cancer·Johanna EkströmJoakim Dillner
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A OberholzerLevi A Garraway
Jan 20, 2012·The New England Journal of Medicine·Fei SuRichard Marais
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 21, 2012·Archives of Dermatology·Victor HuangLynn Cornelius
May 23, 2012·Journal of the American Academy of Dermatology·Emily Y ChuMisha Rosenbach
Jun 5, 2012·The Journal of Infectious Diseases·Michelle R IannaconeDana E Rollison
Jun 26, 2012·Pigment Cell & Melanoma Research·Rachael AnforthPablo Fernandez-Peñas
Jul 10, 2012·The American Journal of Dermatopathology·Nathan T HarveyBenjamin A Wood
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Oct 5, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L MatteiA B Kimball
Nov 9, 2012·The New England Journal of Medicine·Margaret K CallahanPaul B Chapman
Feb 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BoussemartC Robert
Mar 5, 2013·The Oncologist·Mario E LacoutureAndrew K Joe
Jul 23, 2013·Journal of the American Academy of Dermatology·Christine J KoJennifer Nam Choi
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Miles C AndrewsJonathan Cebon
Feb 14, 2014·Cancer Research·Matthew HolderfieldDarrin Stuart
Jul 2, 2014·Clinical Microbiology Reviews·Martyn K WhiteKamel Khalili
Jul 22, 2014·The British Journal of Dermatology·E DikaM La Placa

❮ Previous
Next ❯

Citations

Sep 22, 2016·The Journal of Investigative Dermatology·Daniele ViarisioMassimo Tommasino
Feb 26, 2019·Melanoma Research·Susanne KimeswengerChristian Jantschitsch
Nov 21, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·L Di NardoK Peris
Apr 26, 2020·International Journal of Molecular Sciences·Roberto Corchado-CobosJavier Cañueto
Apr 2, 2020·Reviews in Medical Virology·Luigia BandolinPaolo Boscolo-Rizzo
May 12, 2018·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jaclyn C WatkinsMarisa R Nucci
Apr 22, 2020·Life Science Alliance·Marco GualandiOlga Shakhova
Apr 26, 2020·Journal of the American Academy of Dermatology·Alana DeutschBeth N McLellan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.